日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GRP78 Nanobody-Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy.

GRP78纳米抗体导向免疫毒素通过STING通路激活先天免疫,从而增强肿瘤免疫疗法的疗效

Wang Huifang, Zhou Runhua, Xu Chengchao, Dai Lingyun, Hou Rui, Zheng Liuhai, Fu Chunjin, Shi Guangwei, Wang Jingwei, Li Yang, Cen Jinpeng, Xu Xiaolong, Yu Le, Li Yilei, Wang Jigang, Du Qingfeng, Li Zhijie

Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer

更正:ELOVL2介导的AR稳定作用导致前列腺癌对恩扎卢胺产生耐药性

Cen, Jinpeng; Guo, Jiading; Zeng, Xianzi; Song, Xianlu; Ge, Shengdong; Chen, Mingkun; Li, Qianyi; Yu, Yuzhong; Lv, Daojun; Zhao, Shanchao

ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer.

ELOVL2 介导的 AR 稳定作用导致前列腺癌对恩扎卢胺产生耐药性

Cen Jinpeng, Guo Jiading, Zeng Xianzi, Song Xianlu, Ge Shengdong, Chen Mingkun, Li Qianyi, Yu Yuzhong, Lv Daojun, Zhao Shanchao